Eric Karas Silverback Therapeutics, Inc. (SBTX) insider trading activity

SBTX Quotes by TradingView

Eric Karas is Chief Commercial Officer of Silverback Therapeutics, Inc.. Currently has a direct ownership of 5,693 shares of SBTX, which is worth approximately $0. The most recent transaction as insider was on Sep 18, 2024, when has been sold 10,000 shares (Common Stock) at a price of $14.0 per share, resulting in proceeds of $140,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.69K
n/a 3M change
n/a 12M change
Total Value Held $0

Eric Karas Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 18 2024
SELL
Open market or private sale
$140,000 $14.0 p/Share
10,000 Reduced 63.72%
5,693 Common Stock
Sep 18 2024
BUY
Exercise of conversion of derivative security
$15,000 $1.5 p/Share
10,000 Added 38.92%
15,693 Common Stock
Aug 19 2024
SELL
Open market or private sale
$140,000 $14.0 p/Share
10,000 Reduced 63.72%
5,693 Common Stock
Aug 19 2024
BUY
Exercise of conversion of derivative security
$15,000 $1.5 p/Share
10,000 Added 38.92%
15,693 Common Stock
EK

Eric Karas

Chief Commercial Officer
San Diego, CA

Track Institutional and Insider Activities on SBTX

Follow Silverback Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBTX shares.

Notify only if

Insider Trading

Get notified when an Silverback Therapeutics, Inc. insider buys or sells SBTX shares.

Notify only if

News

Receive news related to Silverback Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SBTX